Reversible ocular adverse effects in melanoma treatment with MEK/BRAF inhibitors
INTRODUCTION
Melanoma, a malignant tumor of melanocytes, presents significant treatment challenges due to its aggressive nature and tendency to metastasize. The advent of targeted therapies, particularly BRAF and MEK inhibitors, has revolutionized the management of BRAF-mutant melanoma, leading...
